No Data
Institutional Investors Control 59% of GeneDx Holdings Corp. (NASDAQ:WGS) and Were Rewarded Last Week After Stock Increased 3.5%
GeneDx Holdings Corp. (NASDAQ:WGS): Is Breakeven Near?
GeneDx Announces Biogen, Praxis Precision Medicines And Stoke Therapeutics As The Founding Partners To Its Patient Access Program For Pediatric Epilepsy, Which Provides Access To Whole Exome Sequencing.
GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients With New Partners
AppLovin, MicroStrategy, and 28 Other Stocks That Could Be Bubbles
Sleep Number, Getty Images, and More Stocks See Action From Activist Investors -- Barrons.com